HDAC-IN-30

Overview

HDAC-IN-30 is a novel multi-target HDAC inhibitor, including HDAC1 ( IC 50 =13.4 nM), HDAC2 ( IC 50 =28.0 nM), HDAC3 ( IC 50 =9.18 nM), HDAC6 ( IC 50 =42.7 nM), HDAC8 ( IC 50 =131 nM). HDAC-IN-30 exhibits potent antitumor efficacy.

Application

Products | Products > Peptides | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > HDAC

Product Information

• Catalog No.: HY-144292
• CAS No.: 2756809-34-2
• Molecular Formula: C22H23N5O3
• Molecular Weight: 405.45
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source